Target intelligence / Profile preview

Glutamate receptor ionotropic NMDA 3B (GluN3B)

Target
GluN3B
Molecular classification
Ion channel, Receptor
01

Overview

The **Glutamate receptor ionotropic NMDA 3B (GluN3B)** is a subunit of non-conventional N-methyl-D-aspartate receptors (NMDARs), which assemble as heterotetrameric ligand-gated cation channels primarily expressed in motor neurons. Unlike typical synaptic NMDARs, GluN3B-containing receptors exhibit low calcium permeability, reduced voltage-dependent magnesium blockade, and unique activation properties, forming complexes with GluN1 and GluN2 subunits activated by glycine (on GluN1/GluN3B) and glutamate (on GluN2), or excitatory glycinergic complexes with GluN1 alone. GluN3B contributes distinct biophysical attributes including activation, deactivation, desensitization kinetics, pH sensitivity, and interactions with allosteric modulators. Structurally, it integrates into tetrameric assemblies with domains like the amino-terminal domain (NTD), ligand-binding domain (LBD), transmembrane domain (TMD), and carboxyl-terminal domain (CTD), influencing channel gating and ion selectivity. In disease contexts, GluN3B plays roles in calcium mobilization into mitochondria and may contribute to neurodegenerative processes through dominant negative effects on NMDAR function. While not prominently linked to approved drugs, its modulation alters synaptic plasticity and could pose therapeutic challenges due to subdued calcium signaling compared to canonical GluN2-containing NMDARs.

Other names
NMDA receptor subunit 3BN-methyl-D-aspartate receptor subunit 3BGRIN3BNMD3BNR3BNMDAR3B
02

Biological functions

Signal transductionCation transportSynaptic plasticity
03

Disease associations

Neurodegenerative diseaseOther
04

Safety considerations

Low calcium permeabilityLow voltage-dependent Mg2+ blockPotential for altered channel kinetics and desensitization

Beyond the preview

Go deeper on Glutamate receptor ionotropic NMDA 3B (GluN3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor ionotropic NMDA 3B (GluN3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call